Advances in the use of topical imiquimod to treat dermatologic disorders
Francesco Lacarrubba, Maria Rita Nasca, Giuseppe MicaliDermatology Clinic, University of Catania, ItalyAbstract: Imiquimod (IQ) is an immune-response modifying agent, first approved by FDA for the topical treatment of external genital and perianal warts in 1997. It induces, through stimulation of To...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2008-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|